Transient Macrophage Depletion Circumvents Scavenging and Redirects Biodistribution of mRNA-Lipid Nanoparticles

被引:0
|
作者
Yuan, Zhefan [1 ]
Luozhong, Sijin [1 ]
Li, Ruoxin [1 ]
Gu, Wenchao [1 ]
Chen, Yu [2 ]
Bhashyam, Dani [1 ]
Lai, Rachel [3 ]
Jiang, Shaoyi [1 ]
机构
[1] Cornell Univ, Meinig Sch Biomed Engn, Ithaca, NY 14853 USA
[2] Cornell Univ, Dept Mat Sci & Engn, Ithaca, NY 14853 USA
[3] Cornell Univ, Smith Sch Chem & Biomol Engn, Ithaca, NY 14853 USA
关键词
macrophage depletion; lipid nanoparticle; mRNAdelivery; enhanced efficiency; redirect biodistributions; IN-VIVO; DELIVERY; CELLS; EXPRESSION; MONOCYTES; POTENT; BRAIN;
D O I
10.1021/acsnano.5c02001
中图分类号
O6 [化学];
学科分类号
0703 ;
摘要
The mononuclear phagocytic system is recognized as a major scavenger of mRNA-lipid nanoparticles (LNPs), clearing and redirecting these particles away from their intended targets and thus diminishing their delivery efficacy. Understanding the mechanism by which mRNA-LNPs interact with phagocytes and how this interaction affects the mRNA transfection is critical to enhancing the delivery of mRNA. In this study, we temporarily depleted both circulating and resident macrophages (MF) and evaluated the transfection efficiency and biodistribution of mRNA-LNPs. We first demonstrated the enhanced liver expression using two liver-tropic formulations and the significant improvement of the in vivo gene editing efficiency of CRISPR-Cas9 in the Ai14 mouse model after MF depletion, providing a versatile strategy for enhanced mRNA delivery to the liver regardless of the formulation employed. We then extended our investigations to lung-tropic and lymphoid-tropic LNP formulations and discovered that MF depletion abolishes the targeting capacities of these non-liver-tropic formulations, providing insights into the organ targeting of LNPs. Finally, we screened and compared various clinically relevant MF depletion methods, providing the translation potential of this method on enhanced hepatic delivery of mRNA.
引用
收藏
页数:12
相关论文
共 39 条
  • [31] Tailored Monoacyl Poly(2-oxazoline)- and Poly(2-oxazine)-Lipids as PEG-Lipid Alternatives for Stabilization and Delivery of mRNA-Lipid Nanoparticles
    He, Xie
    Payne, Thomas J.
    Takanashi, Asuka
    Fang, Yunji
    Kerai, Simran D.
    Morrow, Joshua P.
    Al-Wassiti, Hareth
    Pouton, Colin W.
    Kempe, Kristian
    BIOMACROMOLECULES, 2024, : 4591 - 4603
  • [32] Stability Study of mRNA-Lipid Nanoparticles Exposed to Various Conditions Based on the Evaluation between Physicochemical Properties and Their Relation with Protein Expression Ability
    Kamiya, Mariko
    Matsumoto, Makoto
    Yamashita, Kazuma
    Izumi, Tatsunori
    Kawaguchi, Maho
    Mizukami, Shusaku
    Tsurumaru, Masako
    Mukai, Hidefumi
    Kawakami, Shigeru
    PHARMACEUTICS, 2022, 14 (11)
  • [33] Ionizable lipid nanoparticles deliver mRNA to pancreatic ? cells via macrophage-mediated gene transfer
    Melamed, Jilian R.
    Yerneni, Saigopalakrishna S.
    Arral, Mariah L.
    LoPresti, Samuel T.
    Chaudhary, Namit
    Sehrawat, Anuradha
    Muramatsu, Hiromi
    Alameh, Mohamad-Gabriel
    Pardi, Norbert
    Weissman, Drew
    Gittes, George K.
    Whitehead, Kathryn A.
    SCIENCE ADVANCES, 2023, 9 (04)
  • [34] Macrophage Inhibitor Clodronate Enhances Liver Transduction of Lentiviral but Not AAV Vectors or mRNA Lipid Nanoparticles In Vivo
    Gurung, Sonam
    Touramanidou, Loukia
    Perocheau, Dany
    Cozmescu, Claudiu
    Finn, Patrick
    Cavedon, Alexander
    Siddiqui, Summar
    Martini, Paolo
    Rice, Lisa
    Frassetto, Andrea
    Counsell, John R.
    Waddington, Simon
    Gissen, Paul
    Baruteau, Julien
    MOLECULAR THERAPY, 2023, 31 (04) : 35 - 36
  • [35] Transient growth factor expression via mRNA in lipid nanoparticles promotes hepatocyte cell therapy in mice
    Smith, Anna R.
    Rizvi, Fatima
    Everton, Elissa
    Adeagbo, Anisah
    Wu, Susan
    Tam, Ying
    Muramatsu, Hiromi
    Pardi, Norbert
    Weissman, Drew
    Gouon-Evans, Valerie
    NATURE COMMUNICATIONS, 2024, 15 (01)
  • [36] Insights into the Structure of Comirnaty Covid-19 Vaccine: A Theory on Soft, Partially Bilayer-Covered Nanoparticles with Hydrogen Bond-Stabilized mRNA-Lipid Complexes
    Szebeni, Janos
    Kiss, Balint
    Bozo, Tamas
    Turjeman, Keren
    Levi-Kalisman, Yael
    Barenholz, Yechezkel
    Kellermayer, Miklos
    ACS NANO, 2023, 17 (14) : 13147 - 13157
  • [37] Interaction Kinetics of Individual mRNA-Containing Lipid Nanoparticles with an Endosomal Membrane Mimic: Dependence on pH, Protein Corona Formation, and Lipoprotein Depletion
    Aliakbarinodehi, Nima
    Gallud, Audrey
    Mapar, Mokhtar
    Wesen, Emelie
    Heydari, Sahar
    Jing, Yujia
    Emilsson, Gustav
    Liu, Kai
    Sabirsh, Alan
    Zhdanov, Vladimir P.
    Lindfors, Lennart
    Esbjorner, Elin K.
    Hook, Fredrik
    ACS NANO, 2022, 16 (12) : 20163 - 20173
  • [38] Macrophage Inhibitor Clodronate Enhances Liver Transduction of Lentiviral but Not Adeno-Associated Viral Vectors or mRNA Lipid Nanoparticles in Neonatal and Juvenile Mice
    Touramanidou, Loukia
    Gurung, Sonam
    Cozmescu, Claudiu A.
    Perocheau, Dany
    Moulding, Dale
    Finn, Patrick F.
    Frassetto, Andrea
    Waddington, Simon N.
    Gissen, Paul
    Baruteau, Julien
    CELLS, 2024, 13 (23)
  • [39] Lipid Nanoparticles Targeted to the Optic Nerve Lamina Region Niche as a Potential Genome-Safe Transient Epigenetic Gene Therapy Approach for Age-Related Glaucoma Mediated by Modified Polycistronic mRNA Encoding Epigenome Rejuvenating Oct4, Sox2 and Klf4 Transcription Factors
    Bertolotti, Bryan
    Bertolotti, Roger
    MOLECULAR THERAPY, 2022, 30 (04) : 137 - 137